BIOGENIC SYNTHESIS OF SILVER NANOPARTICLES AND THEIR SYNERGISTIC EFFECT WITH ANTIBIOTICS: A STUDY AGAINST SALMONELLA SP
Objective: In recent era, medical science has turned to a variety of novel products and technologies to halt the spread of infections. The most promising and effective antimicrobial agents being embraced by modern medical science today is silver. With increasing drug-resistance and growing concern regarding the over-prescribing of antibiotics, there has been a resurgent interest in the use of antimicrobial silver. Unlike antibiotics, silver appears to be immune to resistance. Thus, the conjugation of antibiotic with silver nanoparticles would prevent development of resistance of microbes and increase the antimicrobial property of the antibiotic.
Methods: In this manuscript, extracellular biological synthesis of silver nanoparticles was made from Trametes sp. The characterization of the nanoparticles was carried out as well as its antibiotic efficacy was evaluated in addition to the antibiotic combination.
Results: Initially the fungal cell filtrate was challenged with 1Mm AgNO3 solution, in a 250 ml Erlenmeyer flask and agitated at 30 Â°C in dark for 72 h under static conditions at 200 rpm and the silver nanoparticle production was monitored by the change in color and later it was subjected to optical measurements by UV-Vis spectrophotometer. The characters of these silver nanoparticles were further studied by Fourier Transform Infrared (FTIR) Spectroscopy, SEM and TEM studies. The nanoparticles produced during the study period were found to have wider antibacterial property and also it showed the enhanced efficacy in combination with ceftriaxone and ofloxacin against Salmonella sp.
Conclusion: The synergistic mode of antibiosis in between nanoparticles synthesized from Trametes sp. and ceftriaxone, ofloxacin was found to be more effective against Salmonella sp. in the current study.
2. Bansal V, Rautaray D, Bharde A, Ahire K, Sanyal A, Ahmad A. Fungus-mediated biosynthesis of silica and titania particles. J Mater Chem 2005;15:2583-9.
3. Batarseh KI. Anomaly and correlation of killing in the therapeutic properties of silver (I) chelation with glutamic and tartaric acids. J Antimicrob Chemother 2004;54:546-8.
4. Brands AD. Salmonella, Deadly disease and epidemics Philadelphia. Chelsea House publication; 2005.
5. Chitnis V, Chitnis D, Verma S, Hemvani N. Multidrug-resistant Salmonella typhi in India. Lancet 1999;354:514-5.
6. Crump JA, Medalla FM, Joyce KW, Krueger AL, Hoekstra RM, Whichard JM. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the united states national antimicrobial resistance monitoring system, 1996 to 2007. Antimicrob Agents Chemother 2011;55:1148-54.
7. Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, et al. Membrane permeability and regulation of drug â€œInflux and Effluxâ€ in enterobacterial pathogens. Curr Drug Targets 2008;9:750-9.
8. Dibrov P, Dzioba J, Gosink KK, Hase CC. Chemiosmotic mechanism of antimicrobial activity of sliver(+) in vibrio cholerae. Antimicrob Agents Chemother 2002;46:2668-70.
9. Dragieva I, Stoeva S, Stoimenov P, Pavlikianov E, Klabunde K. Complex formation in solutions for chemical synthesis of nanoscaled particles prepared by borohydride reduction process. Nanostruct Mater 1999;12:267-70.
10. Drulis-Kawa Z, Dorotkiewicz-Jach A. Liposomes as delivery systems for antibiotics. Int J Pharm 2010;387:187-98.
11. Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram negative bacteria. Nanomedicine 2010;6:103-9.
12. Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection. J Antimicrob Chemother 2004;54:1019-24.
13. Griggs DJ, Gensberg K, Piddock LJ. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob Agents Chemother 1996;40:1009-13.
14. Kapil A, Sood S, Dash NR, Das BK, Seth P. Ciprofloxacin in typhoid fever. Lancet 2002;354:164.
15. Kenji H, Kazumichi T, Hiroko S, Haruo W. Antibiotic susceptibilities of Salmonella enterica serovar typhi and S. enterica serovar paratyphi a isolated from patients in Japan. Antimicrob Agents Chemother 2001;45:956-8.
16. Klaus T, Joerger R, Olsson E, Granquist CG. Silver based crystalline nanoparticles, microbially fabricated. Proc Natl Acad Sci 1999;96:13611-4.
17. Krishna G, Ram Prasad M, Samatha B, Shesha Venkata Sathya Siva Surya Laxmi Hima Bindu N, Shiva Krishna P, Singara Charya MA. Fungus-mediated synthesis of silver nanoparticles and their activity against gram positive and gram negative bacteria in combination with antibiotics. Walailak J Sci Technol 2015;12:613-22.
18. Labrenz M, Druschel GK, Thomsen ET, Gilbert B, Welch SA, Kemmer KM. Formation of sphalerite (ZnS) deposits in natural biofilms of sulfate-reducing bacteria. Science 2000;290:1744-7.
19. Li P, Li J, Wu C, Wu Q, Jian Li. Synergistic antibacterial effects of Î²-lactam antibiotic combined with silver nanoparticles. Nanotechnology 2005;16:1912-7.
20. Monali G, Jayendra K, Avinash I, Aniket G, Mahendra R. Fungus-mediated synthesis of silver Nanoparticles and their activity against pathogenic fungi in combination with fluconazole. Nanomed Nanotechnol Biol Med 1999;5:382-6.
21. Mujeebur Rahman Khan, Tanveer Fatima Rizvi. Nanotechnology: scope and application in plant disease management. Plant Pathol J 2014;13:214-31.
22. Nair B, Pradeep T. Coalescence of nanoclusters and formation of sub-micron crystallites assisted by Lactobacillus strains. Cryst Growth Des 2002;2:295-8.
23. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009;27:76-83.
24. Roh Y, Bai J, Lauf RJ, Mcmillan AD, Phelps TJ, Rawn CJ. Microbial synthesis of metalsubstituted magnetites. Solid State Commun 2001;118:529-34.
25. Rowe B, Ward LR, Threlfall EJ. Ciprofloxacin-resistant Salmonella typhi in the UK. Lancet 1995;346:1302.
26. Saifuddin N, Wang WC, Nur Yasumira AA. Rapid biosynthesis of silver nanoparticles using culture supernatant of bacteria with microwave irradiation. E J Chem 2009;6:161-70.
27. Sastry M, Ahmad A, Khan MI, Kumar R. Biosynthesis of metal nanoparticles using fungi and Actinomycetes. Curr Sci 2003;85:162-70.
28. Shahnaz M, Anima N. Biosynthesis and assessment of silver nanoparticles with sparfloxacin and ofloxacin synthesized from penicillium sp. on some bacterial pathogens. Int J Appl Biol Pharm Technol 2014;5:108-14.
29. Shaligram SN, Bule M, Bhambure R, Singhal SR, Singh K, Szakacs S, et al. Biosynthesis of silver nanoparticles using aqueous extract from the compactin producing fungi. Process Biochem 2009;44:939-43.
30. Shelar GB, Chavan AM. Fusarium semitectum mediated extracellular synthesis of silver nanoparticles and their antibacterial activity. Int J Biomed Adv Res 2014;5:348-51.
31. Srinivasulu B, Prakasham RS, Jetty A, Srinivas S, Ellaiah P, Ramakrishna SV. Neomycin production with free and immobilized cells of Streptomyces marinensis in an airlift reactor. Process Biochem 2002;48:173-9.
32. Syed Zeeshan Haider Naqvi, Urooj Kiran, Muhammad Ishtiaq Ali, Asif Jamal, Abdul Hameed, Safia Ahmed, et al. Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria. Int J Nanomed 2005;8:3187-95.
33. Yang L, Webster TJ. Nanotechnology controlled drug delivery for treating bone diseases. Expert Opin Drug Delivery 2009;6:851-64.